Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

HIKAL Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.712.67-24.025.3618.42

What is the latest Core EBITDA Growth ratio of HIKAL ?

The latest Core EBITDA Growth ratio of HIKAL is 23.71 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.71
Mar20242.67
Mar2023-24.02
Mar20225.36
Mar202118.42

How is Core EBITDA Growth of HIKAL Trending?

Years Core EBITDA Growth % Change
Mar2025 23.71
788.01
Mar2024 2.67
Positive
Mar2023 -24.02
Negative
Mar2022 5.36
-70.90
Mar2021 18.42 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Growth ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹2,412.4 Cr -4.5% -17.5% -43.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,559.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹164,827.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,942.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹106,825.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,077.0 Cr -3.4% -5.7% 0.3% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

-4.5%

-17.5%

-43.7%

SENSEX

1.7%

-1.7%

10.3%


You may also like the below Video Courses